Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasm Metastasis × eribulin × Clear all

Status

Sponsor Class

Study Type

Interventional 16 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8 Sarcoma 1 Peripheral Nervous System Diseases 1 Neoplasm Metastasis 1 Breast Cancer Organoids 1

Interventions

Blood Specimen Collection 7 Radiosurgery 5 Drug Therapy 5 Therapeutics 4 Surveys and Questionnaires 4 Specimen Handling 4 Radiotherapy 4 Immunotherapy 4 exemestane 3 Hepatectomy 3 Hematologic Tests 3 Docetaxel 3 Data Collection 3 Biological Assay 3 Anastrozole 3 trastuzumab deruxtecan 2 palbociclib 2 enzalutamide 2 apalutamide 2 abiraterone 2 abemaciclib 2 Wearable Electronic Devices 2 Tamoxifen 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2 Radiofrequency Ablation 2 Prednisone 2 Nivolumab 2 Letrozole 2 Fulvestrant 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02551263 2021-06-11

E-SPEC

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡